[Intensive insulin therapy].
Landgraf
R
R
Deutsche Diabetes-Stiftung, Staffelseestrasse 6, 11477 München. ruediger.landgraf@gmx.de
Huber
R-M
RM
Bachmann
A
A
Lohr
R
R
D002648:Child; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D004342:Drug Hypersensitivity / Q000209:etiology; D004487:Edema / Q000139:chemically induced; D005260:Female; D006801:Humans; D007003:Hypoglycemia / Q000139:chemically induced; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000145:classification / Q000627:therapeutic use*; D007328:Insulin / Q000008:administration & dosage / Q000009:adverse effects / Q000145:classification / Q000627:therapeutic use*; D007332:Insulin Infusion Systems / Q000191:economics; D008297:Male; D008875:Middle Aged; D011247:Pregnancy; D011254:Pregnancy in Diabetics / Q000188:drug therapy
D007004:Hypoglycemic Agents; D007328:Insulin